HK1206716A1 - Novel pyridine derivatives - Google Patents

Novel pyridine derivatives Download PDF

Info

Publication number
HK1206716A1
HK1206716A1 HK15107145.2A HK15107145A HK1206716A1 HK 1206716 A1 HK1206716 A1 HK 1206716A1 HK 15107145 A HK15107145 A HK 15107145A HK 1206716 A1 HK1206716 A1 HK 1206716A1
Authority
HK
Hong Kong
Prior art keywords
chloro
pyridin
pyrrolidine
cyclopropanecarbonyl
amide
Prior art date
Application number
HK15107145.2A
Other languages
English (en)
Chinese (zh)
Inventor
莉莉‧安塞爾姆
莉莉‧安塞尔姆
戴維‧班納
戴维‧班纳
沃爾夫岡‧哈普
沃尔夫冈‧哈普
貝恩德‧庫恩
贝恩德‧库恩
‧吕貝斯
T‧吕贝斯
延斯-烏韋‧彼得斯
延斯-乌韦‧彼得斯
貝亞特‧施平勒
贝亚特‧施平勒
Original Assignee
霍夫曼-拉罗奇有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46851300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1206716(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 霍夫曼-拉罗奇有限公司 filed Critical 霍夫曼-拉罗奇有限公司
Publication of HK1206716A1 publication Critical patent/HK1206716A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK15107145.2A 2012-08-21 2013-08-19 Novel pyridine derivatives HK1206716A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12181247.3 2012-08-21
EP12181247 2012-08-21
PCT/EP2013/067218 WO2014029722A1 (en) 2012-08-21 2013-08-19 Novel pyridine derivatives

Publications (1)

Publication Number Publication Date
HK1206716A1 true HK1206716A1 (en) 2016-01-15

Family

ID=46851300

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107145.2A HK1206716A1 (en) 2012-08-21 2013-08-19 Novel pyridine derivatives

Country Status (24)

Country Link
US (1) US9409882B2 (en:Method)
EP (1) EP2888244A1 (en:Method)
JP (1) JP2015530997A (en:Method)
KR (1) KR20150044947A (en:Method)
CN (1) CN104583198A (en:Method)
AR (1) AR092172A1 (en:Method)
AU (1) AU2013305102A1 (en:Method)
BR (1) BR112015003217A2 (en:Method)
CA (1) CA2879796A1 (en:Method)
CL (1) CL2015000354A1 (en:Method)
CO (1) CO7200259A2 (en:Method)
CR (1) CR20150073A (en:Method)
EA (1) EA025166B1 (en:Method)
HK (1) HK1206716A1 (en:Method)
IL (1) IL237128A0 (en:Method)
IN (1) IN2015DN00962A (en:Method)
MA (1) MA37893A1 (en:Method)
MX (1) MX2015002026A (en:Method)
PE (1) PE20150995A1 (en:Method)
PH (1) PH12015500262A1 (en:Method)
SG (1) SG11201500900YA (en:Method)
TW (1) TW201412728A (en:Method)
WO (1) WO2014029722A1 (en:Method)
ZA (1) ZA201500625B (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY196560A (en) * 2016-02-26 2023-04-19 Hoffmann La Roche Novel Pyrrolidine Derivatives
PT3575284T (pt) 2017-01-24 2021-10-01 Astellas Pharma Inc Composto de prolinamida substituído por fenildifluorometilo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903610D0 (sv) 1999-10-06 1999-10-06 Astra Ab Novel compounds II
RU2007129779A (ru) 2005-01-06 2009-02-20 Астразенека Аб (Se) Новые соединения пиридина
BRPI0706725A2 (pt) 2006-01-24 2011-04-05 Actelion Pharmaceuticals Ltda Composto de sais do mesmo , composição farmacêutica , e , uso de um composto
CN104447716A (zh) * 2007-05-09 2015-03-25 沃泰克斯药物股份有限公司 Cftr调节剂
KR20100072098A (ko) 2007-11-30 2010-06-29 에프. 호프만-라 로슈 아게 피리딘 화합물
ES2389042T3 (es) 2008-03-06 2012-10-22 Actelion Pharmaceuticals Ltd. Compuestos de piridina
KR101320790B1 (ko) * 2009-04-20 2013-10-22 에프. 호프만-라 로슈 아게 카텝신 억제제로서의 프롤린 유도체
US8394834B2 (en) * 2009-08-25 2013-03-12 Hoffman-La Roche Inc. Pyrrolidines as NK3 receptor antagonists
EP2760833A1 (en) 2011-09-30 2014-08-06 Endo Pharmaceuticals Inc. Pyridine derivatives

Also Published As

Publication number Publication date
CR20150073A (es) 2015-03-13
IL237128A0 (en) 2015-03-31
AU2013305102A1 (en) 2015-02-12
WO2014029722A1 (en) 2014-02-27
US9409882B2 (en) 2016-08-09
IN2015DN00962A (en:Method) 2015-06-12
KR20150044947A (ko) 2015-04-27
CO7200259A2 (es) 2015-02-27
EA025166B1 (ru) 2016-11-30
CN104583198A (zh) 2015-04-29
EA201590363A1 (ru) 2015-06-30
ZA201500625B (en) 2016-08-31
MA37893A1 (fr) 2017-08-31
US20150307472A1 (en) 2015-10-29
PE20150995A1 (es) 2015-06-29
BR112015003217A2 (pt) 2017-07-04
PH12015500262A1 (en) 2015-03-30
SG11201500900YA (en) 2015-03-30
CL2015000354A1 (es) 2015-10-23
AR092172A1 (es) 2015-03-25
TW201412728A (zh) 2014-04-01
MX2015002026A (es) 2015-06-05
CA2879796A1 (en) 2014-02-27
EP2888244A1 (en) 2015-07-01
JP2015530997A (ja) 2015-10-29

Similar Documents

Publication Publication Date Title
CZ173398A3 (cs) Inhibitory metaloproteinasy, farmaceutické prostředky je obsahující a jejich farmaceutické použití, způsob a meziprodukty pro jejich výrobu
JP2021169505A (ja) ヒト血漿カリクレイン阻害剤
KR20140102253A (ko) 카텝신의 억제제로서의 피롤리딘 유도체
JP2015507000A (ja) 新規ピロリジン誘導体
HK1206716A1 (en) Novel pyridine derivatives
AU2017224343B2 (en) Novel pyrrolidine derivatives
JP6096808B2 (ja) 新規なアゼチジン誘導体
HK1197673A (en) Novel azetidine derivatives
HK1197673B (en) Novel azetidine derivatives
HK1261759A1 (en) Novel pyrrolidine derivatives
HK1261759B (zh) 新吡咯烷衍生物
TW201336837A (zh) 新穎氮雜環丁烷衍生物
HK1197672A (en) Novel pyrrolidine derivatives
HK1101856B (en) Pyrrolidine-3,4-dicarboxamide derivatives
HK1101856A1 (en) Pyrrolidine-3,4-dicarboxamide derivatives